Tokyo, Japan

Jun-ichiro Arai

This inventor holds 1 USPTO granted patent. Top assignee: Terumo Corporation. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun-ichiro Arai. Retrieved from https://idiyas.com/inventor/jun-ichiro-arai-r51xvj5e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun-ichiro Arai: Innovator in 5-Lipoxygenase Inhibitors

Introduction

Jun-ichiro Arai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can inhibit 5-lipoxygenase, an enzyme involved in inflammatory responses.

Latest Patents

Arai holds a patent for "Amide derivatives and 5-lipoxygenase inhibitors containing the same." This invention provides novel amide derivatives that serve as effective ingredients in inhibiting 5-lipoxygenase activity. The compounds demonstrated the ability to inhibit the production of leukotrienes, such as LTC₄ and LTD₄, which are known to induce allergic reactions. Consequently, these amide derivatives can be utilized as effective treatments for allergic asthma and allergic rhinitis.

Career Highlights

Arai is associated with Terumo Corporation, a leading company in the medical technology sector. His work focuses on innovative solutions that address various health challenges through advanced chemical compounds.

Collaborations

Arai has collaborated with esteemed colleagues, including Toshio Wakabayashi and Makoto Takai, to further enhance the research and development of his patented compounds.

Conclusion

Jun-ichiro Arai's contributions to the field of medicinal chemistry, particularly through his patent on 5-lipoxygenase inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new treatments for allergic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…